Investment Analysts’ updated eps estimates for Wednesday, August 16th:
Agilent Technologies (NYSE:A) had its overweight rating reiterated by analysts at Morgan Stanley. They currently have a $7.00 target price on the stock.
Advance Auto Parts (NYSE:AAP) had its underweight rating reissued by analysts at Barclays PLC.
Abeona Therapeutics (NASDAQ:ABEO) was given a $17.00 target price by analysts at Maxim Group. The firm currently has a buy rating on the stock.
Adverum Biotechnologies (NASDAQ:ADVM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $2.75 price target on the stock. According to Zacks, “Adverum Biotechnologies, Inc. is a gene therapy company. The Company discovers and develops novel medicines for patients living with rare diseases. Adverum Biotechnologies Inc, formerly known as Avalanche Biotechnologies Inc., is headquartered in Menlo Park, California. “
American Equity Investment Life Holding (NYSE:AEL) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $28.00 price target on the stock.
Alliqua BioMedical (NASDAQ:ALQA) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Alliqua, Inc. is a biomedical company. The company focused on the development, manufacturing and distribution of proprietary transdermal wound care and drug delivery technologies. Its technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers. The company’s product includes SilverSeal(R) a hydrogel wound dressing with silver coated fibers and Hydress(R) an over-the-counter hydrogel wound dressing. It serves the healthcare industry including wound healing, medical diagnostics and cosmeceuticals. Alliqua, Inc. is headquartered in Langhorne, Pennsylvania. “
Aegean Marine Petroleum Network (NYSE:ANW) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “AEGEAN MARINE PETROLEUM is a marine fuel logistics company that physically supplies and markets refined marine fuel and lubricants to ships in port and at sea. They intends to focus on growing its fleet of double hull bunkering tankers and expanding its service centers in strategic locations worldwide to further enhance the Companys extensive customer relationships and leading industry position. “
Australia & New Zealand Banking Group (OTCMKTS:ANZBY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $26.00 target price on the stock. According to Zacks, “Austria and New Zealand Banking’s principal activities are the provision of general banking services, hire purchase and general finance, life assurance, property development, mortgage lending and other financial services. The Group operates within Australia, New Zealand, Europe, Asia, the Americas and the Middle East. “
Amtech Systems (NASDAQ:ASYS) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $13.00 price target on the stock. According to Zacks, “AMTECH SYSTEMS, INC. is engaged in the manufacture of several items of capital equipment, one of which is patented, used by customers in the manufacture of semiconductors. Co. has recently obtained a U.S. patent on technology on which it expects to base a proposed new photo chemical vapor deposition (CVD) product for use in semiconductor manufacturing facilities. The Company has engaged the University of California, Santa Cruz, to conduct a study to determine the feasibility of such a product. “
Astronics (NASDAQ:ATRO) had its buy rating reaffirmed by analysts at Canaccord Genuity. They currently have a $34.00 price target on the stock. The analysts wrote, “Date and time of first dissemination: August 16, 2017, 11:35 ET Date and time of production: August 16, 2017, 11:35 ET Target Price / Valuation Methodology: Astronics Corporation – ATRO Our new $34 price target is based on the blend of a 17x EPS multiple and a 12x EBITDA multiple applied to our 2018 estimates.””
Biohaven Pharmaceutical Holding Co (NASDAQ:BHVN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company’s pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States. “
Biocept (NASDAQ:BIOC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California. “
Bob Evans Farms (NASDAQ:BOBE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “BOB EVANS FARMS, INC. is divided into two principal industry segments: the food products segment and the restaurant segment. The company owns and operates restaurants, including Bob Evans Restaurants, Owens Family Restaurants, Bob Evans small-town Restaurants and Cantina Del Rio Mexican restaurants. They also produce fresh and fully-cooked sausage products and fresh, deli-style salads which are distributed primarily to grocery stores in the Midwest, Southwest and Southeast. “
Box (NYSE:BOX) had its hold rating reissued by analysts at Stifel Nicolaus. The firm currently has a $17.00 price target on the stock.
BT Group PLC (NYSE:BT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “BT is one of the world’s leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to its customers for use at home, at work and on the move; broadband and internet products and services and converged fixed/mobile products and services. BT consists principally of four lines of business: BT Global Services, BT Retail, BT Wholesale and Openreach. British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group. BT Group plc is listed on stock exchanges in London and New York. “
The Carlyle Group L.P. (NASDAQ:CG) had its buy rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $25.00 price target on the stock.
China Unicom (Hong Kong) (NYSE:CHU) was downgraded by analysts at CLSA from an outperform rating to an underperform rating.
Canadian Pacific Railway Limited (NYSE:CP) (TSE:CP) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $184.00 target price on the stock.
Cray (NASDAQ:CRAY) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $26.00 price target on the stock.
Digital Ally (NASDAQ:DGLY) was given a $8.00 price target by analysts at Westpark Capital. The firm currently has a buy rating on the stock. The analysts wrote, “We believe the company is making solid progress on its legal battle with Axon Enterprise (AAXN). We reduce our PT to $8, as we lower our revenue outlook for DGLY in F’17 and F’18. Disappointing Q2 for DGLY. The company’s topline in Q2 2017 was $3.5 million, a 21% Y/Y decrease, and GAAP EPS were at a loss of ($0.41). Company’s management cited the temporary halt of a commercial client’s order for this big and unexpected decline in its revenues for Q2. For 2Q17, we were expecting revenues of $5.5 million and EPS estimate of ($0.24).””
Dick’s Sporting Goods (NYSE:DKS) was downgraded by analysts at Forward View from a buy rating to a sell rating.
FedEx Corporation (NYSE:FDX) had its neutral rating reiterated by analysts at Stifel Nicolaus.
Home Depot, Inc. (The) (NYSE:HD) was given a $165.00 target price by analysts at Barclays PLC. The firm currently has a buy rating on the stock.
HP (NYSE:HPQ) had its hold rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $14.00 price target on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its buy rating reissued by analysts at Cowen and Company. The analysts wrote, “IOVA reported that the first patient in LN-145’s Phase II cervical cancer study has been.””
ITT (NYSE:ITT) had its buy rating reiterated by analysts at Stifel Nicolaus. They currently have a $49.00 target price on the stock.
Illinois Tool Works (NYSE:ITW) had its hold rating reissued by analysts at Stifel Nicolaus. The firm currently has a $147.00 target price on the stock.
Sidoti started coverage on shares of Knoll (NYSE:KNL). Sidoti issued a buy rating on the stock.
Eli Lilly and (NYSE:LLY) had its sell rating reaffirmed by analysts at BMO Capital Markets. They currently have a $73.00 price target on the stock.
Medley Capital Corporation (NYSE:MCC) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. The firm currently has a $7.00 price target on the stock.
Mesoblast Limited (NASDAQ:MESO) had its buy rating reiterated by analysts at Cantor Fitzgerald. They currently have a $20.00 price target on the stock. The analysts wrote, “Mesoblast announced publication of data from a Phase 1b/2a study with mesenchymal precursor cells (MPCs) in patients with unilateral ACL reconstruction.””
NetApp (NASDAQ:NTAP) had its hold rating reiterated by analysts at Stifel Nicolaus. The firm currently has a $37.00 price target on the stock.
Ocwen Financial Corporation (NYSE:OCN) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $3.00 target price on the stock.
PDC Energy (NASDAQ:PDCE) had its buy rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $76.00 price target on the stock.
Regions Financial Corporation (NYSE:RF) had its hold rating reissued by analysts at Keefe, Bruyette & Woods. The firm currently has a $15.50 target price on the stock.
Scholastic Corporation (NASDAQ:SCHL) had its hold rating reaffirmed by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $44.00 price target on the stock.
THL Credit (NASDAQ:TCRD) had its hold rating reiterated by analysts at Keefe, Bruyette & Woods. They currently have a $10.50 price target on the stock.
Thor Industries (NYSE:THO) had its hold rating reissued by analysts at Stifel Nicolaus.
Verastem (NASDAQ:VSTM) had its buy rating reaffirmed by analysts at Cann.
WPX Energy (NYSE:WPX) was given a $18.00 target price by analysts at Stifel Nicolaus. The firm currently has a buy rating on the stock.
Cimarex Energy (NYSE:XEC) was given a $169.00 price target by analysts at Stifel Nicolaus. The firm currently has a buy rating on the stock.
